GlassScriptPhysician profile
Sean K Graham
NPI 1982894598
$5,235.26
in general payments reported to CMS, 2019-2025
34 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $659 · 2021: $958 · 2022: $536 · 2023: $477 · 2024: $987 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,584.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,583.14 | 2019-2025 | Eterna, Proclaim, Ionicrf |
| Collegium Pharmaceutical, INC. | $665.22 | 2019-2025 | Belbuca |
| Nevro Corp. | $374.53 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $248.18 | 2023-2024 | Ha Minuteman G3-R |
| Si-Bone, INC. | $216.30 | 2021-2023 | |
| Forte Bio-Pharma LLC | $206.30 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Boston Scientific Corporation | $166.96 | 2020-2025 | General - Pain Management |
| Stryker Corporation | $163.39 | 2025 | Spinejack, Optablate, Omnicurve |
| Biotronik Nro, INC. | $152.16 | 2025 | Prospera |
| Globus Medical, INC. | $138.74 | 2025 | Senza |
| Medtronic USA, INC. | $124.85 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.39 | 2020-2025 | Relistor |
| Abbvie INC. | $119.09 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $98.19 | 2019-2021 | |
| Amgen INC. | $94.78 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $90.44 | 2021-2025 | Inceptiv |
| Teva Pharmaceuticals USA, INC. | $88.87 | 2019-2021 | |
| Saluda Medical Americas, INC. | $86.90 | 2024-2025 | Evoke |
| Virtus Pharmaceuticals LLC | $81.24 | 2021-2025 | Levorphanol Tartrate |
| Tersera Therapeutics LLC | $59.14 | 2019-2022 | |
| Valinor Pharma, LLC | $55.06 | 2023-2024 | Movantik |
| Nalu Medical, INC. | $43.14 | 2021-2024 | Nalu Neurostimulation System |
| Supernus Pharmaceuticals, INC. | $38.98 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $35.96 | 2020-2022 | |
| Pfizer INC. | $35.27 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $32.68 | 2020-2021 | |
| Relievant Medsystems, INC. | $20.23 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.72 | 2020 | |
| Allergan, INC. | $15.95 | 2020 | |
| Mdd US Operations, LLC | $13.01 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.47 | 2022 | |
| Stimwave Technologies Incorporated | $12.08 | 2020 | |
| Assertio Therapeutics, INC. | $11.94 | 2019 | |
| Daiichi Sankyo INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.